157 related articles for article (PubMed ID: 33646503)
1. Prostate cancer follow-up costs in Germany from 2000 to 2015.
Michaeli T; Michaeli D
J Cancer Surviv; 2022 Feb; 16(1):86-94. PubMed ID: 33646503
[TBL] [Abstract][Full Text] [Related]
2. Testicular cancer follow-up costs in Germany from 2000 to 2015.
Michaeli T; Michaeli J; Michaeli D
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2249-2258. PubMed ID: 33885951
[TBL] [Abstract][Full Text] [Related]
3. Socio-economic burden of disease: Survivorship costs for bladder cancer.
Michaeli JC; Boch T; Albers S; Michaeli T; Michaeli DT
J Cancer Policy; 2022 Jun; 32():100326. PubMed ID: 35560269
[TBL] [Abstract][Full Text] [Related]
4. Socio-economic burden of disease: Survivorship costs for renal cell carcinoma.
Michaeli JC; Michaeli DT; Boch T; Albers S; Michaeli T
Eur J Cancer Care (Engl); 2022 May; 31(3):e13569. PubMed ID: 35293070
[TBL] [Abstract][Full Text] [Related]
5. Economy of Standards: European Association of Urology Guideline Changes Influence Treatment Costs in Stage I Testicular Cancer Patients.
John A; Baumgart A; Worst T; Heinzelbecker J
Urol Int; 2018; 100(3):279-287. PubMed ID: 29514158
[TBL] [Abstract][Full Text] [Related]
6. [Retrospective SHI (Statutory Health Insurances) real-world study on initial GnRH antagonist and agonist therapy for advanced prostate cancer: prescription patterns and hospital costs in Germany].
Hupe MC; Hammerer P; Ketz M; Kossack N; Colling C; Merseburger AS
Aktuelle Urol; 2020 Jun; 51(3):275-284. PubMed ID: 31745962
[TBL] [Abstract][Full Text] [Related]
7. Budget impact analysis of gene expression tests to aid therapy decisions for breast cancer patients in Germany.
Lux MP; Nabieva N; Hildebrandt T; Rebscher H; Kümmel S; Blohmer JU; Schrauder MG
Breast; 2018 Feb; 37():89-98. PubMed ID: 29128582
[TBL] [Abstract][Full Text] [Related]
8. The Direct and Indirect Costs of Breast Cancer in Poland: Estimates for 2017-2019.
Seweryn M; Banas T; Augustynska J; Lorenc O; Kopel J; Pluta E; Skora T
Int J Environ Res Public Health; 2022 Dec; 19(24):. PubMed ID: 36554267
[TBL] [Abstract][Full Text] [Related]
9. Healthcare Costs Associated with an Adequate Intake of Sugars, Salt and Saturated Fat in Germany: A Health Econometrical Analysis.
Meier T; Senftleben K; Deumelandt P; Christen O; Riedel K; Langer M
PLoS One; 2015; 10(9):e0135990. PubMed ID: 26352606
[TBL] [Abstract][Full Text] [Related]
10. [Cost recovery for the treatment of retinal and vitreal diseases by pars plana vitrectomy under the German DRG system].
Framme C; Franz D; Mrosek S; Helbig H
Ophthalmologe; 2007 Oct; 104(10):866-74. PubMed ID: 17882428
[TBL] [Abstract][Full Text] [Related]
11. Comparing the costs of three prostate cancer follow-up strategies: a cost minimisation analysis.
Pearce AM; Ryan F; Drummond FJ; Thomas AA; Timmons A; Sharp L
Support Care Cancer; 2016 Feb; 24(2):879-886. PubMed ID: 26245495
[TBL] [Abstract][Full Text] [Related]
12. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of the COPD Patient Management European Trial home-based disease management program.
Bourbeau J; Granados D; Roze S; Durand-Zaleski I; Casan P; Köhler D; Tognella S; Viejo JL; Dal Negro RW; Kessler R
Int J Chron Obstruct Pulmon Dis; 2019; 14():645-657. PubMed ID: 30936689
[TBL] [Abstract][Full Text] [Related]
14. Resource use and costs for a glaucoma screening program in Austria: an 8-year review: a cost-consequence analysis based on the Salzburg-Moorfields Collaborative Glaucoma Study.
Hitzl W; Ortner C; Hornykewycz K; Grabner G; Reitsamer HA
Eur J Ophthalmol; 2006; 16(1):92-9. PubMed ID: 16496251
[TBL] [Abstract][Full Text] [Related]
15. Treatment costs of prostate cancer in the first year after diagnosis: a short-term cost of illness study for France, Germany, Italy, Spain and the UK.
Fourcade RO; Benedict A; Black LK; Stokes ME; Alcaraz A; Castro R
BJU Int; 2010 Jan; 105(1):49-56. PubMed ID: 20132102
[TBL] [Abstract][Full Text] [Related]
16. A cost-effectiveness analysis of freeze-only or fresh embryo transfer in IVF of non-PCOS women.
Le KD; Vuong LN; Ho TM; Dang VQ; Pham TD; Pham CT; Norman RJ; Mol BWJ
Hum Reprod; 2018 Oct; 33(10):1907-1914. PubMed ID: 30239784
[TBL] [Abstract][Full Text] [Related]
17. [Direct costs for Parkinson's treatment in private neurology practices in Berlin].
Ehret R; Balzer-Geldsetzer M; Reese JP; Dodel I; Becker E; Christopher A; Friedrich H; Kraemer S; Lüer W; Müngersdorf M; Puzich R; Rohr A; Schultes-Platzek I; Siefjediers V; Tiel-Wilck K; Oertel WH; Dodel R
Nervenarzt; 2009 Apr; 80(4):452-8. PubMed ID: 19252890
[TBL] [Abstract][Full Text] [Related]
18. The economic burden of cancer in the UK: a study of survivors treated with curative intent.
Marti J; Hall PS; Hamilton P; Hulme CT; Jones H; Velikova G; Ashley L; Wright P
Psychooncology; 2016 Jan; 25(1):77-83. PubMed ID: 26087260
[TBL] [Abstract][Full Text] [Related]
19. [Treatment costs of localized prostate cancer in Germany : Economic results from the HAROW observational study].
Reinhold T; Dornquast C; Börgermann C; Weißbach L
Urologe A; 2016 Dec; 55(12):1573-1585. PubMed ID: 27822603
[TBL] [Abstract][Full Text] [Related]
20. Health care cost associated with prostate cancer, androgen deprivation therapy and bone complications.
Krupski TL; Foley KA; Baser O; Long S; Macarios D; Litwin MS
J Urol; 2007 Oct; 178(4 Pt 1):1423-8. PubMed ID: 17706711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
